F13A1 antibody
Quick Overview for F13A1 antibody (ABIN7880462)
Target
See all F13A1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Factor XIIIa Antibody
-
Purification
- Protein G affinity chromatography
-
Immunogen
- A recombinant fragment of human Factor XIIIa was used as the immunogen for the Factor XIIIa antibody.
-
Isotype
- IgG2a, kappa
-
-
-
-
Application Notes
- Optimal dilution of the Factor XIIIa antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the Factor XIIIa antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- F13A1 (Coagulation Factor XIII, A1 Polypeptide (F13A1))
-
Alternative Name
- Factor XIIIa
-
Background
- It recognizes a protein of 83 kDa, which is identified as Factor XIIIa. It has been identified in platelets, megakaryocytes, and fibroblast-like mesenchymal or histiocytic cells in the placenta, uterus, and prostate, monocytes and macrophages and dermal dendritic cells. Anti-factor XIIIa has been found to be useful in differentiating between dermatofibroma (almost all cases are positive), dermatofibrosarcoma protuberans (-/+) and desmoplastic malignant melanoma (-). Anti-factor XIIIa positivity is also seen in capillary hemagioblastoma, hemangioendothelioma, hemangiopericytoma, xanthogranuloma, xanthoma, hepatocellular carcinoma, glomus tumor, and meningioma.
-
UniProt
- P00488
Target
-